1

1CM Inc
CNSX:EPIC

Watchlist Manager
1CM Inc
CNSX:EPIC
Watchlist
Price: 0.165 CAD -15.38%
Market Cap: 19.4m CAD

Relative Value

The Relative Value of one EPIC stock under the Base Case scenario is hidden CAD. Compared to the current market price of 0.165 CAD, 1CM Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPIC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
72
Median 3Y
1.4
Median 5Y
6.2
Industry
2.6
vs History
20
vs Industry
11
Median 3Y
-42.4
Median 5Y
-16.7
Industry
21.4
vs History
22
vs Industry
29
Median 3Y
-30.8
Median 5Y
-27.5
Industry
16.4
vs History
23
vs Industry
17
Median 3Y
-17.2
Median 5Y
-17.2
Industry
22.8
vs History
58
vs Industry
38
Median 3Y
2.7
Median 5Y
1
Industry
2.2
vs History
88
vs Industry
73
Median 3Y
1.4
Median 5Y
6.2
Industry
2.9
vs History
55
vs Industry
44
Median 3Y
6.8
Median 5Y
2
Industry
5.5
vs History
41
vs Industry
23
Median 3Y
8.2
Median 5Y
-15.9
Industry
13
vs History
36
vs Industry
18
Median 3Y
10.8
Median 5Y
-14.3
Industry
16.5
vs History
22
vs Industry
29
Median 3Y
-31
Median 5Y
-31.3
Industry
15.6
vs History
20
vs Industry
21
Median 3Y
-24.4
Median 5Y
-31.7
Industry
18.7
vs History
95
vs Industry
39
Median 3Y
2.3
Median 5Y
6
Industry
1.9

Multiples Across Competitors

EPIC Competitors Multiples
1CM Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
1CM Inc
CNSX:EPIC
19.4m CAD 0.3 11.1 4.7 7.1
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.7 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
492.8B USD 5.3 19.6 16.1 20.8
CH
Roche Holding AG
SIX:ROG
266.1B CHF 4.3 28.2 12 14
UK
AstraZeneca PLC
LSE:AZN
218.6B GBP 5.1 31.4 108.7 159
CH
Novartis AG
SIX:NOVN
216.6B CHF 4.9 18.9 12 15.5
US
Merck & Co Inc
NYSE:MRK
270.8B USD 4.2 14.2 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.5 10.8 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.6B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
CA
1
1CM Inc
CNSX:EPIC
Average P/E: 23.2
11.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.7
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.2
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
CH
Novartis AG
SIX:NOVN
18.9
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
15.5
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
1
1CM Inc
CNSX:EPIC
Average EV/EBITDA: 400.3
4.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
12
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
CH
Novartis AG
SIX:NOVN
12
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
1
1CM Inc
CNSX:EPIC
Average EV/EBIT: 1 712.9
7.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
14
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
159
23%
6.9
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5